Skip to main content
SpringerLink
Log in

Calcific aortic stenosis: Medical and surgical management in the elderly

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Optional statement

Calcific aortic stenosis is the number one indication for surgical valve replacement in the United States. Until recently, it was thought to be a passive degenerative process. However, recent retrospective studies have demonstrated that the risk factors for valvular disease are similar to those of vascular disease. Furthermore, targeting this process with medical therapy may be a future possibility to delay timing of valve replacement in this patient population. This paper reviews the current retrospective studies, experimental studies, and future clinical trials that will impact our understanding of this disease process and the future of medical therapy for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Supino PG, Borer JS, Yin A, et al.: The epidemiology of valvular heart diseases: the problem is growing. Adv Cardiol 2004, 41:9–15. Demonstrates the increasing evidence of valvular heart disease in the aging population in the United States.

    Article  PubMed  Google Scholar 

  2. Soler-Soler J, Galve E: Worldwide perspective of valve disease. Heart 2000, 83:721–725.

    Article  PubMed  CAS  Google Scholar 

  3. Padmavati S: Rheumatic heart disease: prevalence and preventive measures in the Indian subcontinent. Heart 2001, 86:127.

    Article  PubMed  CAS  Google Scholar 

  4. Cheitlin M, Armstrong W, Aurigemma G, et al.: ACC/AHA/ ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 2003, 16:1091–1110.

    PubMed  Google Scholar 

  5. Bonow RO, Carabello B, de Leon AC Jr, et al.: Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998, 98:1949–1984. These are the guidelines for the medical and surgical management of valvular heart disease in the United States.

    PubMed  CAS  Google Scholar 

  6. Ross J Jr, Braunwald E: Aortic stenosis. Circulation 1968, 38(1 suppl):61–67.

    PubMed  Google Scholar 

  7. Pellikka PA, Sarano ME, Nishimura RA, et al.: Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged followup. Circulation 2005, 111:3290–3295.

    Article  PubMed  Google Scholar 

  8. Kannel WB, Dawber TR, Kagan A, et al.: Factors of risk in the development of coronary heart disease—sixyear follow-up experience. The Framingham Study. Ann Intern Med 1961, 55:33–50.

    PubMed  CAS  Google Scholar 

  9. Wilson PW, D’Agostino RB, Levy D, et al.: Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837–1847.

    PubMed  CAS  Google Scholar 

  10. Stewart BF, Siscovick D, Lind BK, et al.: Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997, 29:630–634.

    Article  PubMed  CAS  Google Scholar 

  11. Aronow WS, Ahn C, Kronzon I, Goldman ME: Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001, 88:693–695.

    Article  PubMed  CAS  Google Scholar 

  12. Palta S, Pai AM, Gill KS, Pai RG: New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation 2000, 101:2497–2502.

    PubMed  CAS  Google Scholar 

  13. Peltier M, Trojette F, Sarano ME, et al.: Relation between cardiovascular risk factors and nonrheumatic severe calcific aortic stenosis among patients with a threecuspid aortic valve. Am J Cardiol 2003, 91:97–99.

    Article  PubMed  Google Scholar 

  14. Chui MC, Newby DE, Panarelli M, et al.: Association between calcific aortic stenosis and hypercholesterolemia: is there a need for a randomized controlled trial of cholesterol-lowering therapy? Clin Cardiol 2001, 24:52–55.

    Article  PubMed  CAS  Google Scholar 

  15. Pohle K, Maffert R, Ropers D, et al.: Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001, 104:1927–1932.

    PubMed  CAS  Google Scholar 

  16. O’Brien KD, Kuusisto J, Reichenbach DD, et al.: Osteopontin is expressed in human aortic valvular lesions. Circulation 1995, 92:2163–2168.

    PubMed  CAS  Google Scholar 

  17. Mohler ER 3rd, Adam LP, McClelland P, et al.: Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997, 17:547–552.

    PubMed  Google Scholar 

  18. O’Brien KD, Reichenbach DD, Marcovina SM, et al.: Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of ‘degenerative’ valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996, 16:523–532.

    PubMed  CAS  Google Scholar 

  19. Olsson M, Thyberg J, Nilsson J: Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999, 19:1218–1222.

    PubMed  CAS  Google Scholar 

  20. Sarphie TG: Surface responses of aortic valve endothelia from diet-induced, hypercholesterolemic rabbits. Atherosclerosis 1985, 54:283–299.

    Article  PubMed  CAS  Google Scholar 

  21. Cimini M, Boughner DR, Ronald JA, et al.: Development of aortic valve sclerosis in a rabbit model of atherosclerosis: an immunohistochemical and histological study. J Heart Valve Dis 2005, 14:365–375.

    PubMed  Google Scholar 

  22. Rajamannan NM, Sangiorgi G, Springett M, et al.: Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis 2001, 10:371–374.

    PubMed  CAS  Google Scholar 

  23. Rajamannan NM, Subramaniam M, Springett M, et al.: Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002, 105:2260–2265. Initial study to demonstrate the effects of statins in an experimental model of hypercholesterolemia.

    Article  CAS  Google Scholar 

  24. Drolet MC, Arsenault M, Couet J: Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol 2003, 41:1211–1217.

    Article  PubMed  Google Scholar 

  25. O’Brien KD, Shavelle DM, Caulfield MT, et al.: Association of angiotensin-converting enzyme with lowdensity lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002, 106:2224–2230.

    Article  PubMed  CAS  Google Scholar 

  26. Rajamannan NM, Subramaniam M, Stock SR, et al.: Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart 2005, 91:806–810.

    Article  PubMed  CAS  Google Scholar 

  27. Shavelle DM, Takasu J, Budoff MJ, et al.: HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 2002, 359:1125–1126.

    Article  PubMed  CAS  Google Scholar 

  28. O’Brien KD, Zhao XQ, Shavelle DM, et al.: Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function. J Investig Med 2004, 52:185–191.

    PubMed  CAS  Google Scholar 

  29. Novaro GM, Tiong IY, Pearce GL, et al.: Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001, 104:2205–2209.

    PubMed  CAS  Google Scholar 

  30. Bellamy MF, Pellikka PA, Klarich KW, et al.: Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002, 40:1723–1730.

    Article  PubMed  CAS  Google Scholar 

  31. Rosenhek R, Rader F, Loho N, et al.: Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004, 110:1291–1295.

    Article  PubMed  CAS  Google Scholar 

  32. Cowell SJ, Newby DE, Prescott RJ, et al.: A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005, 352:2389–2397.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Northwestern University Feinberg School of Medicine, 303 E. Chicago, Tarry 12-717, 60611, Chicago, IL, USA

    Nalini M. Rajamannan MD

Authors
  1. Nalini M. Rajamannan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rajamannan, N.M. Calcific aortic stenosis: Medical and surgical management in the elderly. Curr Treat Options Cardio Med 7, 437–442 (2005). https://doi.org/10.1007/s11936-005-0028-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-005-0028-9

Keywords

Search

Navigation